Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Redman

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapyP McLaughlin, L Fuller, J Redman, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|July 15, 2020
[FeFe]-hydrogenase maturation: H-cluster assembly intermediates tracked by electron paramagnetic resonance, infrared, and X-ray absorption spectroscopyBrigitta Németh, Moritz Senger, Holly J Redman, et al.
Chemical Science|June 14, 2021
Spectroscopic investigations under whole-cell conditions provide new insight into the metal hydride chemistry of [FeFe]-hydrogenaseLívia S Mészáros, Pierre Ceccaldi, Marco Lorenzi, et al.
Optics Express|May 14, 2021
Light transport with weak angular dependence in fogBrian Z Bentz, Brian J Redman, John D van der Laan, et al.
Blood|June 1, 1988
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyteF Cabanillas, S Pathak, J Trujillo, et al.
The American Journal of Medicine|June 1, 1986
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalitiesB Koziner, J Myers, C Cirrincione, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
Chemical Science|June 7, 2021
Characterization of a putative sensory [FeFe]-hydrogenase provides new insight into the role of the active site architectureHenrik Land, Alina Sekretareva, Ping Huang, et al.
Journal of the American Chemical Society|January 27, 2025
Probing the Influence of the Protein Scaffold on H-Cluster Reactivity via Gain-of-Function Studies─Improved H<sub>2</sub> Evolution and O<sub>2</sub> Tolerance through Rational Design of [FeFe] HydrogenasePrincess R Cabotaje, Alina Sekretareva, Moritz Senger, et al.
Optics Letters|April 15, 2022
Incorporating the effects of objects in an approximate model of light transport in scattering mediaBrian Z Bentz, Christian A Pattyn, John D van der Laan, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapyP McLaughlin, L Fuller, J Redman, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|July 15, 2020
[FeFe]-hydrogenase maturation: H-cluster assembly intermediates tracked by electron paramagnetic resonance, infrared, and X-ray absorption spectroscopyBrigitta Németh, Moritz Senger, Holly J Redman, et al.
Chemical Science|June 14, 2021
Spectroscopic investigations under whole-cell conditions provide new insight into the metal hydride chemistry of [FeFe]-hydrogenaseLívia S Mészáros, Pierre Ceccaldi, Marco Lorenzi, et al.
Optics Express|May 14, 2021
Light transport with weak angular dependence in fogBrian Z Bentz, Brian J Redman, John D van der Laan, et al.
Blood|June 1, 1988
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyteF Cabanillas, S Pathak, J Trujillo, et al.
The American Journal of Medicine|June 1, 1986
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalitiesB Koziner, J Myers, C Cirrincione, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
Chemical Science|June 7, 2021
Characterization of a putative sensory [FeFe]-hydrogenase provides new insight into the role of the active site architectureHenrik Land, Alina Sekretareva, Ping Huang, et al.
Journal of the American Chemical Society|January 27, 2025
Probing the Influence of the Protein Scaffold on H-Cluster Reactivity via Gain-of-Function Studies─Improved H<sub>2</sub> Evolution and O<sub>2</sub> Tolerance through Rational Design of [FeFe] HydrogenasePrincess R Cabotaje, Alina Sekretareva, Moritz Senger, et al.
Optics Letters|April 15, 2022
Incorporating the effects of objects in an approximate model of light transport in scattering mediaBrian Z Bentz, Christian A Pattyn, John D van der Laan, et al.
Pageof 12